image
Crinetics Pharmaceuticals, Inc. CRNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 54.72
-8.28 %
$ 5.07 B
Market Cap
-14.55
P/E
BALANCE SHEET
635 M ASSETS
80.41%
Growth Rates
1Year 80.41%
3Years 51.30%
5Years 29.96%
7Years 75.08%
10Years 0.00%
96.2 M LIABILITIES
168.49%
Growth Rates
1Year 168.49%
3Years 87.82%
5Years 53.78%
7Years 26.27%
10Years 0.00%
539 M EQUITY
222.75%
Growth Rates
1Year 222.75%
3Years 73.43%
5Years 70.54%
7Years 89.85%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Crinetics Pharmaceuticals, Inc.
image
Current Assets 574 M
Cash & Short-Term Investments 559 M
Receivables 9.35 M
Other Current Assets 6.25 M
Non-Current Assets 61.2 M
Long-Term Investments 2.47 M
PP&E 57.4 M
Other Non-Current Assets 1.3 M
Current Liabilities 43.9 M
Accounts Payable 6.55 M
Short-Term Debt 4.17 M
Other Current Liabilities 33.2 M
Non-Current Liabilities 52.3 M
Long-Term Debt 47.6 M
Other Non-Current Liabilities 4.75 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 54.9 32.7 200.7 93.1 40.3 45.0 14.2 12.2
Short Term Investments 503.7 301.8 133.0 77.8 78.1 118.9 0 0
Receivables 9.4 0 2.0 1.8 0 0 0.7 72 K
Inventory 0 0 8.1 (1.8) (1.4) 0 0.1 98 K
Other Current Assets 6.2 10.8 8.1 4.8 1.3 0.9 0.2 43 K
Total Current Assets 574.2 345.2 344.7 177.5 123.3 166.7 15.2 12.4
PP&E 57.4 5.0 4.7 5.4 6.5 4.2 0.4 0.2
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 2.5 2.0 1.0 0.5 0.5 0.5 0 0
Other Long Term Assets 1.3 37 K 0.6 40 K 82 K 0 33 K 10 K
Other Assets 1 0 0 0 0 0 0 0
Total Assets 635.4 352.2 351.0 183.4 130.4 171.4 15.6 12.6
LIABILITIES
Accounts Payable 6.5 6.9 3.4 3.5 2.7 1.5 0.4 0.3
Short Term Debt 4.2 1.1 0 0 0 0 0 49 K
Other Current Liabilities 31.2 17.5 12.6 7.0 5.6 6.5 0.5 0.5
Total Current Liabilities 43.9 27.7 16.0 10.5 8.3 7.9 0.9 0.9
Long Term Debt 47.6 2.0 3.1 4.0 4.8 0 0 0.2
Deferred Tax Income 0 (6.1) 0 0 0 0 0 0
Other Liabilities 0 0 2 K 23 K 49 K 3.3 29.7 17.8
Total Liabilities 96.2 35.8 19.1 14.5 13.2 11.2 30.6 18.8
EQUITY
Common Stock 1 191.8 759.4 607.6 336.5 210.8 24 K 1 K 1 K
Retained Earnings (653.7) (439.2) (275.3) (167.6) (93.8) (43.4) (16.3) (7.1)
Other Accumulative Comprehensive Income/Loss 1.0 (3.9) (0.4) 25 K 0.1 61 K (0.3) (0.2)
Total Equity 539.1 (439.2) (275.3) (167.6) (93.8) (43.4) (15.0) (6.2)
Total Liabilities and Equity 635.4 (403.3) (256.2) (153.1) (80.6) (32.2) 15.6 12.6
SHARES OUTSTANDING
Common Shares Outstanding 58.1 52.0 38.4 30.4 24.2 12.1 13.9 13.9